<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18711262</article-id><article-id pub-id-type="pmc">2636130</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_5_355_42410</article-id><article-categories><subj-group subj-group-type="heading"><subject>Guest Editorial</subject></subj-group></article-categories><title-group><article-title>Human immunodeficiency virus and the ophthalmologist</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Soman</surname><given-names>Rajeev</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Purandare</surname><given-names>Bharat</given-names></name><degrees>MD</degrees><aff>P. D. Hinduja National Hospital and Medical Research Centre,Veer Savarkar Marg, Mumbai - 400 016, India.Email: <email>rajeev.soman@gmail.com</email></aff></contrib></contrib-group><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2008</year></pub-date><volume>56</volume><issue>5</issue><fpage>355</fpage><lpage>356</lpage><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properlycited.</license-p></license></permissions></article-meta></front><body><p>Human immunodeficiency virus (HIV)/ acquired immune deficiency syndrome (AIDS) is one of the most feared infectiousdiseases of the late 20<sup>th</sup> century. It has made a profound impact on contemporary medical practice, public health prioritiesand every aspect of modern society. All medical practitioners must be aware of the basics of HIV/AIDS transmission, pathogenesis,clinical manifestations and the principles of management. At the dawn of the 20<sup>th</sup> century, Sir William Osler said, &#x02033;Toknow Syphilis is to know medicine&#x02033;. AIDS appears to be the modern equivalent of syphilis in this regard.</p><p>The first cases of HIV/AIDS were reported in 1981 amongst a group of homosexual males in Philadelphia.<xref ref-type="bibr" rid="ref1">1</xref> The first Indiancase of HIV was reported in a commercial sex worker from Chennai in 1986.<xref ref-type="bibr" rid="ref2">2</xref> Since then, HIV hasmade rapid inroads into our country with the trend of the pandemic shifting from the so-called high-risk groups (commercial sex workers,injection drug users, multiple sexual partners, men having sex with men) to the low-risk general population due to heterosexualtransmission. The national adult prevalence of HIV disease is 0.36% with around 2.51 million people being infected with thisdeadly virus according to the recent National AIDS Control Organization (NACO) estimates.<xref ref-type="bibr" rid="ref3">3</xref>Murthy discusses the socioeconomic impact produced by HIV in India in his article in this symposium.<xref ref-type="bibr" rid="ref4">4</xref></p><p>HIV/AIDS is undoubtedly a multisystem disorder but ophthalmic disease does affect 70-80% of patients with HIV infectionsometime during the natural history of their infection.<xref ref-type="bibr" rid="ref5">5</xref> Various studies have demonstrated that40-45% of HIV-infected patientsdo have some or other ophthalmic manifestations when examined by an ophthalmologist.<xref ref-type="bibr" rid="ref6">6</xref> HIV canaffect the eye either directly or indirectly by means of various opportunistic infections. The immunology and immunopathogenesis of HIVinfection is discussed in the introductory article by Sudarshan <italic>et al</italic>.,<xref ref-type="bibr" rid="ref7">7</xref> inthis symposium. Eye manifestations pointing towards HIV infectionin an undiagnosed and otherwise asymptomatic patient include <italic>Herpes zoster</italic> ophthalmicus, molluscum contagiosuminvolving the eyelids and cotton wool spots in the retina. Cotton wool spots are reportedly the most common ophthalmoscopic finding inHIV-infected patients.<xref ref-type="bibr" rid="ref8">8</xref></p><p>There are many ophthalmic problems that a physician should rule out with the help of an ophthalmologist before initiationof antiretroviral therapy (ART). The spectrum of HIV-associated ophthalmic disease is very broad and ranges from adnexaldisorders to posterior segment diseases including the optic nerve and the optic tract.<xref ref-type="bibr" rid="ref8">8</xref> Diseasesof the adnexa include <italic>Herpes Zoster</italic>ophthalmicus, conjunctival molluscum contagiosum and involvement in exfoliative dermatitis such as Steven-Johnson syndrome.Anterior segment disorders comprise <italic>Herpes</italic> keratitis, candidial keratitis, syphilis and uveitis (either primary orsecondary such as in the setting of reactive arthritis). A detailed review of various anterior segment disorders in HIV infection ispresented in the following symposium by Biswas <italic>et al</italic>.<xref ref-type="bibr" rid="ref9">9</xref></p><p>Non-infectious posterior segment manifestations include HIV-retinopathy, cotton-wool spots, hemorrhages and telangiectasiasaffecting the retina, and optic disc atrophy. Infectious posterior segment disorders include the sight-threatening<italic>Cytomegalovirus</italic> ocular disease, <italic>Toxoplasma</italic> retinochoroiditis, <italic>Candida</italic>endophthalmitis, tubercular choroiditis, <italic>Cryptococcal</italic> or <italic>Pneumocystis</italic>choroiditis and acute retinal necrosis. A review of various posterior segment manifestations along with very useful illustrationswill be found in Bankar&#x02032;s article in this issue.<xref ref-type="bibr" rid="ref10">10</xref></p><p>Due to the potentially devastating and rapid course of retinal opportunistic infections, all persons with HIV disease shouldundergo routine baseline ophthalmologic evaluations. Any HIV-infected person who experiences ocular symptoms also shouldreceive prompt and competent ophthalmologic care as a delay in therapy can lead to irreversible visual loss. In patients withearly-stage HIV disease (CD4 count &#x0003e;300 cells/&#x000b5;L), ocular syndromes associated with immunosuppression are uncommon.Nonetheless, eye infections associated with sexually transmitted diseases (STDs) such as <italic>Herpes simplex</italic> virus,<italic>Gonorrhea</italic>, and <italic>Chlamydia</italic> may be more common in HIV-infected persons; therefore, clinicians shouldscreen for HIV in the presence of these infections. Patients become more susceptible to cytomegalovirus (CMV) disease, particularly whentheir CD4 count drops below 50 cells/&#x000b5;L. These patients need to be educated regarding the retinal symptoms in addition to theneed for regular ophthalmologic examinations. A close coordination is thus required between the referring physician and theophthalmologist for the optimal treatment of any given patient.</p><p>Ophthalmologists also play a pivotal role in the diagnosis and management of many eye conditions in the setting of HIVinfection. Placement of an intraocular ganciclovir implant by an experienced ophthalmologist achieves higher intraocular levels ofganciclovir than systemic therapy alone and reduces the chances of relapse of CMV ocular disease.<xref ref-type="bibr" rid="ref11">11</xref> Surgical reattachment of theretinal detachment occurring secondary to CMV disease often helps to restore the vision, at least partially. Fortunately, the adventof combination ART has resulted in a welcome decline in the incidence of this disease. Antiretroviral therapy also prevents CMVrelapse. Indeed, it appears that patients with treated CMV retinitis may safely discontinue anti-CMV therapy if their CD4 counts riseto greater than 100 cells/&#x000b5;L.<xref ref-type="bibr" rid="ref12">12</xref> Kempen,<xref ref-type="bibr" rid="ref13">13</xref> inhis article in this symposium, discusses various antiretroviral drugs approved for use andbroad perspectives of the medical management of HIV infection with the help of highly active antiretroviral therapy (HAART).</p><p>The eye is also the one of the victims of drug-related adverse reactions. Drugs like rifabutin, especially when combined withazole antifungal agents can induce uveitis. Cidofovir used in some cases of CMV retinitis is also associated with uveitis andreduction in intraocular pressure.</p><p>In the era of the availability of potent ART through government as well as private sectors, today&#x02032;s ophthalmologists need tobe aware of immune reconstitution inflammatory syndromes. Uveitis occurs on this basis after initiation of ART and tends to involvethe vitreous, macula and optic nerve and occasionally goes on to form cataracts and epiretinal membranes. Eye evaluation includingfundoscopy is thus an integral part of routine follow-up of patients on ART. Impact of HAART on ophthalmic manifestations isaptly dealt with in the article by Venkatesh <italic>et al</italic>.,<xref ref-type="bibr" rid="ref14">14</xref> in this issue.</p><p>Occupational exposure to HIV is a significant health hazard for the treating clinicians including the eye surgeons. Exposureto patient&#x02032;s blood or other infectious secretions may occur in the setting of outpatient management or operation theaters. Theneed for universal precautions including gloves and protective eyewear cannot be overemphasized. In addition to appropriatepreventive measures, there is also a compelling need of having an access to the post-exposure prophylaxis (PEP) drugs in theoperation theaters, hospital casualty and the intensive care unit. The PEP drugs are highly effective in preventing occupationaltransmission, provided that the PEP therapy is initiated as quickly as possible (preferably within 1&#x02013;2 h of exposure).</p><p>An improved communication between the two broad specialties of HIV medicine and ophthalmology will definitely go a longway in the battle against this dreadful disease.</p></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="book"><source><italic>Pneumocystis</italic> pneumonia</source><year>1981</year><publisher-loc>Los Angeles</publisher-loc><publisher-name>MMWR Weekly</publisher-name><fpage>1</fpage><lpage>3</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="webpage"><source>International AIDS charity (Avert) website. Timeline of AIDS in Asia</source><date-in-citation>accessed on 2008 Jul 14</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.avert.org/asia-aids-timeline.htm">http://www.avert.org/asia-aids-timeline.htm</ext-link></comment></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="webpage"><source>National AIDS Control organization website. HIV data</source><date-in-citation>accessed on 2008 Jul 14</date-in-citation><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.nacoonline.org/Quick_Links/HIV_Data">http://www.nacoonline.org/Quick_Links/HIV_Data</ext-link></comment></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murthy</surname><given-names>GVS</given-names></name></person-group><article-title>The socioeconomic impact of HIV/AIDS in India and its relevance to eye care</article-title><source>Indian J Ophthalmol</source><year>2008</year><volume>56</volume><fpage>395</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18711268</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>ET</given-names></name><name><surname>Margolis</surname><given-names>TP</given-names></name></person-group><article-title>Ocular manifestations of HIV infection</article-title><source>N Engl J Med</source><year>1998</year><volume>339</volume><fpage>236</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">9673303</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>J</given-names></name><name><surname>Kumaraswamy</surname><given-names>N</given-names></name><name><surname>Soloman</surname><given-names>S</given-names></name></person-group><article-title>Ophthalmic manifestations of Human Immunodeficiency Virus (HIV) in India</article-title><source>Indian J Ophthalmol</source><year>1999</year><volume>47</volume><fpage>87</fpage><lpage>93</lpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudharshan</surname><given-names/></name></person-group><article-title>Introduction and immunopathogenesis of AIDS</article-title><source>Indian J Ophthalmol</source><year>2008</year><volume>56</volume><fpage>357</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18711263</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="webpage"><source>University of California San Francisco website. HIV insite portal. Clinical manifestations of HIV infection. Ophthalmicmanifestations of HIV infection</source><date-in-citation>cited on 2008 Jul 14</date-in-citation><comment>Available from:<ext-link ext-link-type="uri" xlink:href="http://hivinsite.ucsf.edu/InSite?page=kb-00anddoc=kb-04-01-12">http://hivinsite.ucsf.edu/InSite?page=kb-00anddoc=kb-04-01-12</ext-link></comment></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>J</given-names></name></person-group><article-title>Anterior segment manifestations of HIV/AIDS</article-title><source>Indian J Ophthalmol</source><year>2008</year><volume>56</volume><fpage>363</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">18711264</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banker</surname><given-names>A</given-names></name></person-group><article-title>Posterior segment manifestations of HIV/AIDS</article-title><source>Indian J Ophthalmol</source><year>2008</year><volume>56</volume><fpage>377</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">18711265</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Bartlett</surname><given-names>J</given-names></name><name><surname>Joel</surname><given-names>G</given-names></name></person-group><article-title>Neurologic complications of HIV: CMV retinitis</article-title><source>Medical management of HIV infection</source><year>2007</year><publisher-loc>Baltimore, Maryland, USA</publisher-loc><publisher-name>Publication of John Hopkins University</publisher-name></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sterling</surname><given-names>TR</given-names></name><name><surname>Chaisson</surname><given-names>RE</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Mandell</surname><given-names>GL</given-names></name><name><surname>Dolin</surname><given-names>R</given-names></name><etal/></person-group><article-title>General Clinical manifestations of HIV infection (including ocular disease)</article-title><source>Principles and practice of infectious diseases</source><year>2005</year><comment>Chapter 117</comment></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempen</surname><given-names>J</given-names></name></person-group><article-title>Medical management of human immunodeficiency virus infection</article-title><source>Indian J Ophthalmol</source><year>2008</year><volume>56</volume><fpage>385</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">18711266</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatesh</surname><given-names>K</given-names></name></person-group><article-title>Impact of highly active antiretroviral therapy on ophthalmic manifestations in HIV/AIDS</article-title><source>Indian J Ophthalmol</source><year>2008</year><volume>56</volume><fpage>391</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">18711267</pub-id></element-citation></ref></ref-list></back></article>